Literature DB >> 16718381

Analysis of loss of heterozygosity and immunohistochemistry in BRCA1 gene in sporadic breast cancers.

Kada Peela Bheeman Dinesh1, Halagowder Devaraj, Vadivel Murugan, Ramamurthy Rajaraman, Sivasidhambaram Niranjali.   

Abstract

BRCA1 is a tumour suppressor gene (TSG), which predisposes cancer to both breast and ovary. The primary objective of the present study is to ascertain the involvement of BRCA1 gene in the pathogenesis of sporadic breast cancer women in Chennai (South India) by analysing its protein expression by immunohistochemistry (IHC) and loss of heterozygosity (LOH) for confirmation of the involvement of TSG in the study population. We found down regulation of BRCA1 protein (54%) in IHC and it was correlated with the clinicopathological parameters of the patients. We found near significant correlation (P < 0.063) between BRCA1 protein expression and clinicopathological parameters. We found 30% LOH in our study and it was also correlated with the clinicopathological parameters. No correlation was found between LOH and clinicopathological parameters. Though we found no correlation, the results revealed in this study support the involvement of BRCA1 TSG in the pathogenesis of sporadic breast cancer women in Chennai (South India).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16718381     DOI: 10.1007/s11010-005-9097-z

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  31 in total

1.  Loss of heterozygosity (LOH) at p53 is correlated with LOH at BRCA1 and BRCA2 in various human malignant tumors.

Authors:  D Tong; E Kucera; E Schuster; R K Schmutzler; H Swoboda; A Reinthaller; S Leodolter; R Zeillinger
Journal:  Int J Cancer       Date:  2000-10-15       Impact factor: 7.396

2.  Tumour-specific distribution of BRCA1 promoter region methylation supports a pathogenetic role in breast and ovarian cancer.

Authors:  T Bianco; G Chenevix-Trench; D C Walsh; J E Cooper; A Dobrovic
Journal:  Carcinogenesis       Date:  2000-02       Impact factor: 4.944

3.  Prognostic significance of BRCA1 expression in Japanese sporadic breast carcinomas.

Authors:  Q Yang; T Sakurai; I Mori; G Yoshimura; M Nakamura; Y Nakamura; T Suzuma; T Tamaki; T Umemura; K Kakudo
Journal:  Cancer       Date:  2001-07-01       Impact factor: 6.860

4.  Analysis of BRCA1 involvement in breast cancer in Indian women.

Authors:  P H Pestonjamasp; I Mittra
Journal:  J Biosci       Date:  2000-03       Impact factor: 1.826

5.  Inhibition of BRCA-1 expression by benzo[a]pyrene and its diol epoxide.

Authors:  B D Jeffy; E U Schultz; O Selmin; J M Gudas; G T Bowden; D Romagnolo
Journal:  Mol Carcinog       Date:  1999-10       Impact factor: 4.784

6.  Location of BRCA1 in human breast and ovarian cancer cells.

Authors:  R Scully; S Ganesan; M Brown; J A De Caprio; S A Cannistra; J Feunteun; S Schnitt; D M Livingston
Journal:  Science       Date:  1996-04-05       Impact factor: 47.728

7.  Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite length polymorphisms.

Authors:  P A Futreal; P Söderkvist; J R Marks; J D Iglehart; C Cochran; J C Barrett; R W Wiseman
Journal:  Cancer Res       Date:  1992-05-01       Impact factor: 12.701

8.  Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.

Authors:  D F Easton; D T Bishop; D Ford; G P Crockford
Journal:  Am J Hum Genet       Date:  1993-04       Impact factor: 11.025

9.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

10.  Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.

Authors:  R Gonzalez; J M Silva; G Dominguez; J M Garcia; G Martinez; J Vargas; M Provencio; P España; F Bonilla
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640

View more
  2 in total

1.  Targeting the Akt/mTOR pathway in Brca1-deficient cancers.

Authors:  T Xiang; Y Jia; D Sherris; S Li; H Wang; D Lu; Q Yang
Journal:  Oncogene       Date:  2011-01-17       Impact factor: 9.867

2.  BRCA1 Promoter Methylation and Expression - Associations with ER+, PR+ and HER2+ Subtypes of Breast Carcinoma

Authors:  Mohit Kumar; Ram Krishna Sahu; Aditi Goyal; Sonal Sharma; Navneet Kaur; Ravi Mehrotra; Usha Rani Singh; Suresh Hedau
Journal:  Asian Pac J Cancer Prev       Date:  2017-12-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.